Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03114319
Title Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Dana Farber Cancer Center Active, not recruiting Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Sarah Cannon Research Institute Active, not recruiting Nashville Tennessee 37221 United States Details
Novartis Investigative Site Recruiting Toronto Ontario M5G 1Z5 Canada Details
Novartis Investigative Site Recruiting Kobe-shi Hyogo 650-0017 Japan Details
Novartis Investigative Site Recruiting Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Recruiting Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Recruiting Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Recruiting Rotterdam 3075 EA Netherlands Details
Novartis Investigative Site Recruiting Singapore 169610 Singapore Details
Novartis Investigative Site Recruiting Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Recruiting Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Recruiting Madrid 28009 Spain Details
Novartis Investigative Site Recruiting Madrid 28034 Spain Details
Novartis Investigative Site Recruiting Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field